ºÚÁÏÕýÄÜÁ¿Health Abstract Submissions Now Closed
Scientific Content Criteria & Requirements for The ºÚÁÏÕýÄÜÁ¿Health Meeting Abstracts
Please also review the ºÚÁÏÕýÄÜÁ¿Microbe 2026 general abstract guidelines as well for a smooth abstract submission process.
- Data must be objectively gathered, analyzed and reported; conclusions must be supported by results.
- Abstracts must demonstrate scientific rigor, including transparency in design, methodology, data collection, analysis and interpretation.
- When applicable, include details on sample size, randomization, blinding and replication.
- Include producing organism, purification steps, physical/chemical characterization, structures, MICs and ED50 values.
- A chemical structure or literature reference must be provided; abstracts without defined structures should be submitted to the ºÚÁÏÕýÄÜÁ¿Mechanism Discovery Meeting.
Review & Selection
Abstracts are evaluated based on:- Originality: novelty, innovation or advancement of knowledge.
- Scientific merit and importance: relevance and potential impact on the field.
- Research design and analysis: clarity, rigor and appropriateness of methods.
- Conclusions: strength and justification based on data.
- Quality of presentation: clarity, adherence to instructions and language quality.
ºÚÁÏÕýÄÜÁ¿Mechanism Discovery Key Focus Areas Accepting Abstracts
Explore diagnostic microbiology and clinical lab operations that improve the speed, accuracy and equity of infectious disease detection, including molecular diagnostics, automation, AI, stewardship and decentralized testing for clinical and public health use.
Apply diagnosis, treatment and clinical management of infectious diseases across patient populations and health care settings, including adult and pediatric care, infections in immunocompromised patients, global disease patterns and hospital acquired infections, with an emphasis on evidence-based practice to improve patient outcomes.
Use microbial surveillance systems, including genomic and environmental surveillance, AMR tracking and real-time outbreak response, to generate actionable insights to prevent, detect and respond to infectious disease threats across human, animal and environmental health.
Explore functions, interactions and therapeutic potential of microbiomes across humans, animals, plants and the environment, integrating systems of biology and engineered interventions to advance applications in health, agriculture and climate resilience.
Use of Artificial Intelligence (AI), Chatbots or Large Language Models (LLMs)
Please refere to our general guidelines on the use of AI, Chatbots and Large Language Models (LLMs).
Decisions of the program committee are final. Abstracts submitted under the ‘Oral or Poster’ presentation preference are not guaranteed an oral presentation assignment. Abstracts not selected for oral presentation will be assigned as posters.
Case Study Submissions Now Open
ºÚÁÏÕýÄÜÁ¿Microbe 2026 will also feature case studies presented by participants in the ºÚÁÏÕýÄÜÁ¿Health Meeting program. We invite all participants to submit case studies for consideration, with priority given to medical technologists and trainees (for example, students, pathology residents or infectious disease fellows).
Those chosen will receive mentorship from an invited speaker and will present their case study to peers during a 10–15-minute presentation. Please note that the selection decision is final and cannot be appealed.
All submitted cases must adhere to HIPAA guidelines, including the removal of any identifying information. Submissions that fail to comply will be disqualified.
Case Study submission is open through January 30.
Technical Support
If you have any questions regarding use of the abstract submission site, please contact technical support at ºÚÁÏÕýÄÜÁ¿Support.
Questions?
Check out the 'Abstracts Questions' section of our FAQ page.